[{"NetIncomeLoss_1_Q2_USD":-69592000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":38904000.0,"RestrictedCashCurrent_0_Q2_USD":2395000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_2_Q2_USD":1301000.0,"InterestPaidNet_2_Q2_USD":6788000.0,"InventoryFinishedGoods_0_Q2_USD":2589000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":302000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":2395000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":45750000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":52.52,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":658480.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":12948000.0,"AssetsCurrent_0_Q2_USD":524859000.0,"LongTermDebt_0_Q2_USD":195189000.0,"NoninterestExpense_2_Q2_USD":7366000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"NoninterestExpense_1_Q2_USD":3677000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":61093000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":1332000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":748000.0,"NoninterestIncome_2_Q2_USD":493000.0,"NoninterestIncome_1_Q2_USD":164000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":7091677.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":7091677.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":403000.0,"LossContingencyLossInPeriod_2_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":12584000.0,"CommonStockSharesIssued_0_Q2_shares":62379118.0,"LossContingencyAccrualProvision_2_Q2_USD":0.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":376291000.0,"Assets_0_Q2_USD":614972000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":120059000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":62312418.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":61116707.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"ResearchAndDevelopmentExpense_2_Q2_USD":102641000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":51784000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":42.32,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":117587000.0,"InventoryRawMaterials_0_Q2_USD":9013000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":259000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-7088000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-3522000.0,"CommonStockValue_0_Q2_USD":62000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":2908000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":170068.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":-4655000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":2072000.0,"AvailableForSaleSecuritiesCurrent_0_Q2_USD":18085000.0,"CostsAndExpenses_2_Q2_USD":224032000.0,"CostsAndExpenses_1_Q2_USD":113625000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":47670000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q2_USD":376248000.0,"OperatingLeaseLiability_0_Q2_USD":81684000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-78000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-259000.0,"IncreaseDecreaseInOtherAccruedLiabilities_2_Q2_USD":7683000.0,"Liabilities_0_Q2_USD":299206000.0,"ShareBasedCompensation_2_Q2_USD":41184000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":76441000.0,"OtherAssetsNoncurrent_0_Q2_USD":1522000.0,"OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease_2_Q2_USD":0.0,"OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease_1_Q2_USD":0.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-69411000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-144522000.0,"IncreaseDecreaseInInventories_2_Q2_USD":6841000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":419311000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":49421000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_2_Q2_USD":838000000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1_Q2_USD":408000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":3739404.0,"VariableLeaseCost_2_Q2_USD":2000000.0,"VariableLeaseCost_1_Q2_USD":1200000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1130991000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-75496000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":2044000.0,"CommonStockSharesOutstanding_0_Q2_shares":62379118.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":12852000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-78000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":1962000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":21644000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":259000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":259000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-123577000.0,"InventoryWorkInProcess_0_Q2_USD":36389000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":12222000.0,"LiabilitiesCurrent_0_Q2_USD":72675000.0,"NetIncomeLoss_2_Q2_USD":-144522000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":36775000.0,"ReceivablesNetCurrent_0_Q2_USD":19544000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":76338.0,"CashEquivalentsAtCarryingValue_0_Q2_USD":358206000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":476000.0,"AdditionalPaidInCapital_0_Q2_USD":1446393000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":889000.0,"LongTermDebtNoncurrent_0_Q2_USD":149268000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":19928000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":421706000.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":49000.0,"AccountsPayableCurrent_0_Q2_USD":9198000.0,"InterestExpenseDebt_2_Q2_USD":42189000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":5958000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":47555000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-112000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"AvailableForSaleSecuritiesGrossUnrealizedGains_2_Q2_USD":43000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":35903000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":13368000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":7121000.0,"IncreaseDecreaseInAccountsPayableTrade_2_Q2_USD":-9730000.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"OperatingIncomeLoss_2_Q2_USD":-137434000.0,"OperatingIncomeLoss_1_Q2_USD":-66070000.0,"InventoryNet_0_Q2_USD":47991000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":43.57,"PreferredStockValue_0_Q2_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":19.82,"OperatingLeaseCost_2_Q2_USD":5600000.0,"OperatingLeaseCost_1_Q2_USD":2400000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":614972000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":150000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1920000.0,"StockholdersEquity_0_Q2_USD":315766000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":822000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.12,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-2.32,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":86598000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q2_USD":421706000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":49627000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_1_Q2_USD":-65000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":19970000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":40350000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":19330000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":5243000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":4771000.0,"Ticker":"GBT","CIK":"1629137","name":"GLOBAL BLOOD THERAPEUTICS, INC.","OfficialName":"Global Blood Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"2248655788.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210803"}]